Navigation Links
IGF-II, Non-Extraction ELISA Test

ProductsIGF-II, Non-Extraction ELISA Test
Company Diagnostic Systems Laboratories, Inc.
Item IGF-II, Non-Extraction ELISA Test
Features Inquire
Description Insulin-like growth factor II (IGF-II) is a 7.5 kDa peptide which is secreted primarily by the liver and is postulated to have mitogenic and metabolic actions involved in cellular growth. The actions of IGF-II are mediated by binding to target cell receptors. IGF-II binds with high affinity to the Type II IGF receptor, a monomeric protein which also serves as the receptor for mannose-6-phosphate [1]. However, it is believed that binding to the Type I IGF and insulin receptors may mediate the mitogenic actions of IGF-II [2,3]. In the circulation, the interaction of IGF-II with these receptors appears to be regulated by IGF-binding proteins (IGFBPs). IGF-II is mainly carried in blood in the high molecular weight ternary complex with IGFBP-3 and ALS, and a smaller proportion of IGF-II circulates in association with other IGFBPs [4,5]. Serum IGF-II concentrations increase with postnatal age showing a moderate age-related increase throughout childhood and puberty, and there is no significant variability during the day [6,7]. Serum levels of IGF-II are also dependent on GH secretion. IGF-II levels are low in GH deficiency [7], although IGF-II levels may also decrease in GH excess and with exogenous administration of IGF-I [3]. The combined molar concentrations of IGF-I and IGF-II (i.e. Total serum IGF) is proportional to serum IGFBP-3 and consequently may be useful for evaluation of GH-related disorders [8].

  1. Morgan DO, et al. Nature 329:301-307, 1987.
  2. Conover CA, et al. Biochem Biophys Res Commun 139:501-508, 1986.
  3. Gluckman PD & Ambler GR. Mol Cell Endocrinol 92:C1-C3, 1993
  4. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989.
  5. Rechler M. Vit Horm 47:1-114, 1993.
  6. Lee PDK & Rosenfeld RG. Pediatrician 14:154-161, 1987.
  7. Rosenfeld RG, et al. J. Pediatr 109:428-433, 1986.
  8. Baxter R & Martin J. J Clin Invest 78: 1504-1512, 1986.
Info Diagnostic Systems Laboratories, Inc.
Customer Service: (800) 231-7970
Web site: http://www.dslabs.com

Related medicine products :

1. IGF-II, Non-Extraction IRMA Test
2. IGF-II, w/ Extraction ELISA Test
3. IGF-II, w/ Extraction IRMA Test
4. IGF-I ELISA Test (Non-Extraction)
5. IGF-I IRMA Test (Non-Extraction)
6. Microplate ELISA Washers - Manual Microplate Washer
7. Microplate ELISA Washers - Automated Microplate Washer
8. Vitamin D 25-Hydroxy ELISA 026-AC-57F1 Bone and Mineral Metabolism
9. RELISA ANA Screening System
10. BioCheck hCG ELISA
11. Human Chorionic Gonadotropin (HCG) ELISA Kit
The Omni-Flex System provides the capability to change frame arms in the middle of surgery while retaining exposure with tension on the incision. The system is also strong enough to be stable for lar
...actor System represents the most widely accepted "...array of retraction components provides numerous s...lti-directional exposure of the surgical field. In...pecific procedures: IMA Kit / Bariatric Kit / Spin...
...he Alexis Wound Retractor provides circumferential...ination. For open surgery, the Alexis Retractor pr...ion size. For laparoscopic surgery, the Alexis Ret...protection when an organ or specimen requires remo...
Pipetman Concept is a revolutionary motorized electronic pipette. Conceived with simplicity and flexibility in mind, Pipetman Concept features exclusive multifunction characteristics and a direct pip
Medicine Products:
(Date:10/7/2008)...uncement of planned bequest comes at stem cell sym...wswire/ -- Just over one year,ago, retail pioneer ...the,University of Michigan, to endow a new researc...reventing human disease., Today, at the institute...that he will bequeath an additional $22 million to...
(Date:10/7/2008)...0,000 PEOPLE ACROSS THE NATION HAVE SAID ,I VOTE F...ALLAS, Oct. 7 /PRNewswire/ -- To aid and help educ... the positions of presidential candidates,Senators...nd cancer issues,the Susan G. Komen for the Cure(...sources available on its web site --, http://www.I...
(Date:10/7/2008)... Wyndstorm Corporation ( www.wyndstorm.co...ia company, announced a key win with Muve, Inc. ( ...ing plan program design to promote Muve,s activity...ign project will ultimately help Muve,s corporate ...employees via interactive messaging, rewards progr...
(Date:10/7/2008)... means better access, more choices for Indiana hea...FORT WAYNE, Ind., Oct. 7 /PRNewswire/ -- Lutheran ...ement to partner with Consumers Life Insurance,Com...ervice to consumers in,12 Indiana counties includi...ork partnership is Fort Wayne,s Lutheran,Hospital,...
Breaking Medicine News(10 mins):Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 2Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 3Health News:Consumers Life Expands Healthcare Network in Northeast Indiana 2
...ers at the University of Michigan C.S. Mott Childr...are at an increased// risk for influenza-related c...e flu, even when they visit their doctor during fl... Archives of Pediatric and Adolescent Medicine, th...
...national team of researchers is developing a new g...between donors and recipients//. The Bloodchip giv...sts. The current tests look for blood types while ...es”. A spokeswoman for the National Blood Service...
...ican Physical Therapy Association (APTA) has said ... part of workplace injuries. It is a repetitive-st...of the popular BlackBerry devices. "The use of PD... longer limited to the eight hours spent in the wo...
...ionel Richie was so fearful over his daughter Nico...r to the doctors personally and find out the probl...cared for his daughter's health and wanted to know...der. He says: "Believe me, I've checked it out t...
Other Medicine News:Health News:Few Medicaid Kids with Asthma Get Recommended Flu Shot 2Health News:Few Medicaid Kids with Asthma Get Recommended Flu Shot 3Health News:Novel genetic blood test 2
(Date:10/6/2008)...rate to Improve Patient Safety, WASHINGTON, Oct. ...of,Cardiology in collaboration with the American C...Association today released consensus guidelines,ou...of ulcers and,gastrointestinal (GI) bleeding among...gs (NSAIDs) along with antiplatelet agents., Gast...
(Date:10/6/2008)... Therapy is More Likely to Induce Steroid-Free R...d Immunomodulator, Azathioprin...sented for the first time,from the Phase 3b Study ...dulators and Biologic Therapy (SONIC) may provide ... with moderate to severe Crohn,s disease.,Accordin...
(Date:10/6/2008)...severe patients achieved endoscopic,response and m...at Week 10,in data from a 54-week open-label study...logy (ACG) Annual Scientific Meeting, ORLANDO, Fl...a from a,large, prospective study investigating en...a biologic compound. The data presented at the Ame...
(Date:10/6/2008)... Weeks of Radiation Therapy -, Event: Watch Single...day, October 22, 2008, 3 - 4 p.m. by visiting ...a., Oct. 6 / Questions raced through ...t cancer in May. Would she have the,tumor removed ...therapy?, , To view the Multimedia News Release,...
Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Aberrations in region of chromosome 1q21 1 associated with broad range of disorders in children 4819 1Aberrations in region of chromosome 1q21 1 associated with broad range of disorders in children 4819 2Aberrations in region of chromosome 1q21 1 associated with broad range of disorders in children 4819 3How do race genetics and health care disparities affect spread of HIV 3F 4816 1Eatn Park to Thank Guests for Their Support of the Chains Decision to Go Smoke Free 26272 19 11s Health Effects Lingered for Years 26268 19 11s Health Effects Lingered for Years 26268 29 11s Health Effects Lingered for Years 26268 3
...(BUSINESS WIRE)--May 25, 2007 - ARIAD,Pharmaceutic...ical,investigators from leading cancer centers wil...g trials of the Company,s novel mTOR,inhibitor, AP...ty,of Clinical Oncology (ASCO) in Chicago, Illinoi...he Phase 2 trial of single-agent,AP23573 in patien...
...(BUSINESS WIRE)--May 24, 2007 - A new analysis,has...igned in ways,that inadvertently omit women and Af...niversity School of Medicine,researcher who led th...tists that strict study eligibility criteria can h...ng data from a pool of 100,000 alcohol treatment,p...
Other Medicine Technology:Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 2Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 3